These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2576444)

  • 1. Pharmacokinetics of 2',3'-dideoxycytidine in rats: application to interspecies scale-up.
    Ibrahim SS; Boudinot FD
    J Pharm Pharmacol; 1989 Dec; 41(12):829-34. PubMed ID: 2576444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 2',3'-dideoxycytidine after high-dose administration to rats.
    Ibrahim SS; Boudinot FD
    J Pharm Sci; 1991 Jan; 80(1):36-8. PubMed ID: 1849573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic evaluation of drug interactions with anti-human immunodeficiency virus drugs. V. Effect of soluble CD4 on 2',3'-dideoxycytidine kinetics in monkeys.
    Qian M; Swagler AR; Fong KL; Crysler CS; Mehta M; Gallo JM
    Drug Metab Dispos; 1992; 20(3):396-401. PubMed ID: 1355714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic evaluation of drug interactions with anti-human immunotrophic virus (HIV) Drugs. III. 2',3'-Dideoxycytidine (ddC) and zidovudine in monkeys.
    Qian MX; Swagler AR; Mehta M; Vishwanathan CT; Gallo JM
    Pharm Res; 1992 Feb; 9(2):224-7. PubMed ID: 1313173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rats.
    Abobo CV; Ni L; Schinazi RF; Liotta DC; Boudinot FD
    J Pharm Sci; 1994 Jan; 83(1):96-9. PubMed ID: 8138919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pregnancy, mode of administration and neonatal age on the pharmacokinetics of zalcitabine (2', 3'-dideoxycytidine) in the pigtailed macaque (Macaca nemestrina).
    Tuntland T; Nosbisch C; Unadkat JD
    J Antimicrob Chemother; 1997 Nov; 40(5):687-93. PubMed ID: 9421317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders.
    Klecker RW; Collins JM; Yarchoan RC; Thomas R; McAtee N; Broder S; Myers CE
    J Clin Pharmacol; 1988 Sep; 28(9):837-42. PubMed ID: 2852679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dose and sex on the pharmacokinetics of piroxicam in the rat.
    Roskos LK; Boudinot FD
    Biopharm Drug Dispos; 1990 Apr; 11(3):215-25. PubMed ID: 2328308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of anti-HIV nucleosides in microswine.
    Swagler AR; Qian MX; Gallo JM
    J Pharm Pharmacol; 1991 Dec; 43(12):823-6. PubMed ID: 1687578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of pharmacokinetic interaction between dipyridamole and zalcitabine in rats.
    Abobo CV; Xian Y
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1045-50. PubMed ID: 9449537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 1-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-methyluracil (L-FMAU) in rats.
    Wright JD; Ma T; Chu CK; Boudinot FD
    Pharm Res; 1995 Sep; 12(9):1350-3. PubMed ID: 8570534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of the bioavailability and pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS or AIDS-related complex.
    Gustavson LE; Fukuda EK; Rubio FA; Dunton AW
    J Acquir Immune Defic Syndr (1988); 1990; 3(1):28-31. PubMed ID: 2152803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.
    Asif G; Hurwitz SJ; Gumina G; Chu CK; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 2005 Feb; 49(2):560-4. PubMed ID: 15673733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interspecies differences and scaling for the pharmacokinetics of xanthine derivatives.
    Tsunekawa Y; Hasegawa T; Nadai M; Takagi K; Nabeshima T
    J Pharm Pharmacol; 1992 Jul; 44(7):594-9. PubMed ID: 1357141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
    Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK
    Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interspecies scaling and pharmacokinetic parameters of 3TC in humans.
    Hussey EK; Donn KH; Daniel MJ; Hall ST; Harker AJ; Evans GL
    J Clin Pharmacol; 1994 Oct; 34(10):975-7. PubMed ID: 7530728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
    Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2',3'-dideoxycytidine.
    Zeidner NS; Strobel JD; Perigo NA; Hill DL; Mullins JI; Hoover EA
    Antiviral Res; 1989 Apr; 11(3):147-60. PubMed ID: 2544137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacokinetics of beta-L-dioxolane-cytidine, a novel anticancer agent, in rats.
    Moore LE; Boudinot FD; Chu CK
    Cancer Chemother Pharmacol; 1997; 39(6):532-6. PubMed ID: 9118465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.